Studio Investment Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755K Buy
7,910
+366
+5% +$35.1K 0.13% 103
2026
Q1
$782K Buy
7,544
+1,035
+16% +$117K 0.14% 98
2025
Q4
$656K Buy
6,509
+714
+12% +$77.5K 0.12% 106
2025
Q3
$715K Buy
5,795
+348
+6% +$43.2K 0.13% 103
2025
Q2
$654K Buy
5,447
+467
+9% +$62.3K 0.13% 103
2025
Q1
$733K Buy
4,980
+671
+16% +$102K 0.15% 89
2024
Q4
$700K Buy
4,309
+1,740
+68% +$285K 0.15% 93
2024
Q3
$419K Buy
+2,569
New +$381K 0.09% 123

Other funds holding CLX

Studio Investment Management's CLX Position: Q2 2026 in Review

Studio Investment Management increased its Clorox (CLX) stake by 4.9% in Q2 2026, buying an estimated $35.1K and bringing the position to 7,910 shares worth $755K. The position accounts for 0.13% of the portfolio, ranked #103.

Studio Investment Management first reported a position in CLX in Q3 2024 and has held it in 8 quarters since. The position peaked at $782K in Q1 2026. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Studio Investment Management held 7,910 shares of Clorox worth $755K as of Q2 2026.
  • Studio Investment Management bought 366 Clorox shares in Q2 2026, an estimated $35.1K.
  • Clorox made up 0.13% of Studio Investment Management's portfolio in Q2 2026, its #103 holding.
  • Studio Investment Management first reported a position in Clorox in Q3 2024 and has held it in 8 quarters since.
  • Studio Investment Management's Clorox position peaked at $782K in Q1 2026.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.